These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 3162823

  • 1. Protein kinase C activities with different characteristics, including substrate specificity, from two human HL-60 leukemia cell variants.
    Homma Y, Gemmell MA, Huberman E.
    Cancer Res; 1988 May 15; 48(10):2744-8. PubMed ID: 3162823
    [Abstract] [Full Text] [Related]

  • 2. Novobiocin- and phorbol-12-myristate-13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase II activity.
    Constantinou A, Henning-Chubb C, Huberman E.
    Cancer Res; 1989 Mar 01; 49(5):1110-7. PubMed ID: 2537141
    [Abstract] [Full Text] [Related]

  • 3. Phorbol myristate acetate inhibits phosphoinositol lipid-specific phospholipase C activity via protein kinase C activation in conditions inducing differentiation in HL-60 cells.
    Cost H, Barreau P, Basset M, Le Peuch C, Geny B.
    Cell Biochem Funct; 1991 Oct 01; 9(4):263-73. PubMed ID: 1807858
    [Abstract] [Full Text] [Related]

  • 4. Specific protein phosphorylation in human promyelocytic HL-60 leukemia cells susceptible or resistant to induction of cell differentiation by phorbol-12-myristate-13-acetate.
    Anderson NL, Gemmell MA, Coussens PM, Murao S, Huberman E.
    Cancer Res; 1985 Oct 01; 45(10):4955-62. PubMed ID: 3861240
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of phorbol ester-induced phenotypic differentiation of HL-60 cells by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, a protein kinase inhibitor.
    Matsui T, Nakao Y, Koizumi T, Katakami Y, Fujita T.
    Cancer Res; 1986 Feb 01; 46(2):583-7. PubMed ID: 3606750
    [Abstract] [Full Text] [Related]

  • 6. Role of protein kinase C in phosphorylation of vinculin in adriamycin-resistant HL-60 leukemia cells.
    Aquino A, Hartman KD, Knode MC, Grant S, Huang KP, Niu CH, Glazer RI.
    Cancer Res; 1988 Jun 15; 48(12):3324-9. PubMed ID: 3130982
    [Abstract] [Full Text] [Related]

  • 7. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60).
    Kraft AS, Baker VV, May WS.
    Oncogene; 1987 May 15; 1(2):111-8. PubMed ID: 3325877
    [Abstract] [Full Text] [Related]

  • 8. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
    Murao S, Gemmell MA, Callaham MF, Anderson NL, Huberman E.
    Cancer Res; 1983 Oct 15; 43(10):4989-96. PubMed ID: 6576856
    [Abstract] [Full Text] [Related]

  • 9. Up regulation of the phorbol ester receptor-protein kinase C in HL-60 variant cells.
    Perrella FW, Hellmig BD, Diamond L.
    Cancer Res; 1986 Feb 15; 46(2):567-72. PubMed ID: 3000578
    [Abstract] [Full Text] [Related]

  • 10. Effects of phorbol ester on translocation and down-regulation of protein kinase C and phosphorylation of endogenous proteins in human acute myeloid leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1a.
    Shoji M, Girard PR, Charp PA, Koeffler HP, Vogler WR, Kuo JF.
    Cancer Res; 1987 Dec 01; 47(23):6363-70. PubMed ID: 3479244
    [Abstract] [Full Text] [Related]

  • 11. 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine(H-7), a potent inhibitor of protein kinases, inhibits the differentiation of HL-60 cells induced by phorbol diester.
    Nishikawa M, Uemura Y, Hidaka H, Shirakawa S.
    Life Sci; 1986 Sep 22; 39(12):1101-7. PubMed ID: 3462446
    [Abstract] [Full Text] [Related]

  • 12. Potentiation of the activity of nitric oxide by the protein kinase C activator phorbol ester in human myeloid leukemic HL-60 cells: association with enhanced fragmentation of mature genomic DNA.
    Jun CD, Park SJ, Choi BM, Kwak HJ, Park YC, Kim MS, Park RK, Chung HT.
    Cell Immunol; 1997 Feb 25; 176(1):41-9. PubMed ID: 9070316
    [Abstract] [Full Text] [Related]

  • 13. Aluminum-induced DNA synthesis in osteoblasts: mediation by a G-protein coupled cation sensing mechanism.
    Quarles LD, Hartle JE, Middleton JP, Zhang J, Arthur JM, Raymond JR.
    J Cell Biochem; 1994 Sep 25; 56(1):106-17. PubMed ID: 7806584
    [Abstract] [Full Text] [Related]

  • 14. Decreased expression of type II protein kinase C in HL-60 variant cells resistant to induction of cell differentiation by phorbol diester.
    Nishikawa M, Komada F, Uemura Y, Hidaka H, Shirakawa S.
    Cancer Res; 1990 Feb 01; 50(3):621-6. PubMed ID: 2297701
    [Abstract] [Full Text] [Related]

  • 15. Subcellular distribution of protein kinase C in rat colonic epithelial cells with different proliferative activities.
    Craven PA, DeRubertis FR.
    Cancer Res; 1987 Jul 01; 47(13):3434-8. PubMed ID: 3581079
    [Abstract] [Full Text] [Related]

  • 16. Protein kinase C and platelets.
    Hidaka H, Kawamoto S.
    Rev Clin Basic Pharm; 1985 Jul 01; 5(3-4):235-325. PubMed ID: 2950546
    [No Abstract] [Full Text] [Related]

  • 17. A calcium-dependent protein kinase is present in tetrahymena.
    Hegyesi H, Csaba G.
    Cell Biochem Funct; 1994 Sep 01; 12(3):221-6. PubMed ID: 7955132
    [Abstract] [Full Text] [Related]

  • 18. Double minute chromatin bodies and other chromosome alterations in human myeloid HL-60 leukemia cells susceptible or resistant to induction of differentiation by phorbol-12-myristate-13-acetate.
    Au WW, Callaham MF, Workman ML, Huberman E.
    Cancer Res; 1983 Dec 01; 43(12 Pt 1):5873-8. PubMed ID: 6580064
    [Abstract] [Full Text] [Related]

  • 19. Human leukemia cell lines with comparable receptor binding characteristics but different phenotypic responses to phorbol diesters.
    Weinberg JB, Misukonis MA, Goodwin BJ.
    Cancer Res; 1984 Mar 01; 44(3):976-80. PubMed ID: 6318990
    [Abstract] [Full Text] [Related]

  • 20. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S.
    Cancer Res; 2001 Mar 15; 61(6):2583-91. PubMed ID: 11289135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.